Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Lymphocytic, Acute, L2”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Large-scale testing (Phase 3)Study completedNCT00382109
What this trial is testing

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionGraft Versus Host Disease+3 more
Children's Oncology Group 146
Early research (Phase 1)UnknownNCT05005299
What this trial is testing

Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, Acute, L1Leukemia, Lymphoblastic, Acute, L2+3 more
Melbourne Health 18
Testing effectiveness (Phase 2)Looking for participantsNCT05648019
What this trial is testing

CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

Who this might be right for
Lymphoblastic LeukemiaLymphoblastic Leukemia in ChildrenLymphoblastic Leukemia, Acute Adult+3 more
KK Women's and Children's Hospital 40
Early research (Phase 1)Study completedNCT00103701
What this trial is testing

BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Myeloid, Chronic-phaseLeukemia, Lymphoblastic, Acute, Philadelphia-positive
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT00101595
What this trial is testing

Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Chronic Myeloid LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-positive
Bristol-Myers Squibb 96
Testing effectiveness (Phase 2)Study completedNCT00003700
What this trial is testing

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 163
Large-scale testing (Phase 3)Study completedNCT00123487
What this trial is testing

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

Who this might be right for
Myeloid Leukemia, Chronic, Accelerated PhaseLeukemia, Lymphoblastic, Acute, Philadelphia-Positive
Bristol-Myers Squibb 638
Early research (Phase 1)Study completedNCT00005593
What this trial is testing

Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Case Comprehensive Cancer Center 31
Large-scale testing (Phase 3)WithdrawnNCT00019409
What this trial is testing

Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Looking for participantsNCT05043571
What this trial is testing

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LeukemiaLymphoblastic Leukemia, Acute Adult+4 more
National University Hospital, Singapore 20
Testing effectiveness (Phase 2)Study completedNCT00298987
What this trial is testing

Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate

Who this might be right for
Leukemia, Myeloid, ChronicLeukemia, Lymphocytic, Acute, L2
Bristol-Myers Squibb 400
Testing effectiveness (Phase 2)Looking for participantsNCT07387926
What this trial is testing

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositivePhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 50
Large-scale testing (Phase 3)Study completedNCT00002812
What this trial is testing

Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 2,078
Testing effectiveness (Phase 2)Study completedNCT00109837
What this trial is testing

S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
SWOG Cancer Research Network 79
Early research (Phase 1)Looking for participantsNCT05495035
What this trial is testing

Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLeukemia, Lymphoblastic, Acute, Philadelphia-PositiveRelapsed Leukemia+1 more
Institute of Hematology & Blood Diseases Hospital, China 19
Testing effectiveness (Phase 2)Study completedNCT00458848
What this trial is testing

Chemotherapy With or Without Imatinib and/or Peripheral Stem Cell Transplant in Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 470
Testing effectiveness (Phase 2)Study completedNCT00061945
What this trial is testing

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Who this might be right for
Acute Undifferentiated LeukemiaB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic Leukemia+11 more
National Cancer Institute (NCI) 302
Testing effectiveness (Phase 2)UnknownNCT02766868
What this trial is testing

Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL

Who this might be right for
Lymphoblastic Leukemia, Acute, Adult
Shanghai Jiao Tong University School of Medicine 20
Not applicableEnded earlyNCT01761682
What this trial is testing

Acute Lymphoblastic Leukemia Registry at Asan Medical Center

Who this might be right for
Leukemia, Acute LymphoblasticPrecursor B-Cell Lymphoblastic LeukemiaLeukemia, Biphenotypic, Acute+2 more
Asan Medical Center 200
Not applicableStudy completedNCT00049569
What this trial is testing

Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
L1 Childhood Acute Lymphoblastic LeukemiaL2 Childhood Acute Lymphoblastic LeukemiaNon-T, Non-B Childhood Acute Lymphoblastic Leukemia+2 more
National Cancer Institute (NCI) 126
Next Page